NCT06821360View on ClinicalTrials.gov

Assessing Remote Confirmation of Type 1 Diabetes

Enrolling by invitationOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 3, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
DiabetesType 1 Diabetes (T1D)
Interventions
DIAGNOSTIC_TEST

C-peptide test

Participants collect a single home finger-prick sample and post to the clinical laboratory for C-peptide analysis (a measure of endogenous insulin production).

Trial Locations (1)

EX2 5DW

NIHR Exeter Clinical Research Facility, Exeter

Sponsors
All Listed Sponsors
collaborator

NIHR Exeter Clinical Research Facility

NETWORK

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Royal Devon and Exeter NHS Foundation Trust

OTHER